Radiotherapy After Surgery Significantly Reduces Atypical Meningioma Recurrence, Clinical Trial Finds
The Roam trial found 5-year disease-free survival rose to 80% with radiotherapy, while quality of life and cognition stayed the same.
10 Articles
10 Articles
Radiotherapy after surgery significantly reduces atypical meningioma recurrence, clinical trial finds
Atypical meningiomas are tumors that originate in the meninges and are associated with a high risk of recurrence. Until now, it was unclear whether patients benefit from radiotherapy after complete surgical removal of the tumor. An international study in which MedUni Vienna played a key role provides new evidence that radiotherapy can significantly reduce the recurrence rate. The results, recently published in The Lancet, are set to be incorporated into national and international guidelines.
Radiotherapy after surgery ‘reduces risk of recurrence of certain brain cancers’
Cancer returns almost 50% of the time among patients with these aggressive brain tumours.
Landmark trial changes how atypical meningioma is treated after surgery
Results from the international ROAM trial, published today in The Lancet and presented at EANO 2026 (Meeting of the European Association of Neuro-Oncology), give people with atypical meningioma clear evidence […]
International study provides new evidence for treatment after removal of the tumor ATYPICAL MENINGEOMES ARE DECLARED BY THE HIRNHEAUT, which ARE ASSOCIATED WITH A HIGH RETURNING RISK. BETHER WAS NOT ONLY DECLARED, OB PATIENT: CALL FOR FULL OPERATIONAL RETURNING OF THE TUMOR OF A STRAHLENT HERAPY. NUN LEARNING AN INTERNATIONAL STUDY WITH MEASURING PARTICIPATION OF THE MEDUNI VIENNA NEW [...] The article Brain Skin Tumors: Radiation Therapy Reduce…
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium












